Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-048234
Filing Date
2007-07-30
Accepted
2007-07-30 17:46:41
Documents
1
Period of Report
2007-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd167339.html 3  
1 FORM 3 rrd167339.xml 3 3182
  Complete submission text file 0001181431-07-048234.txt   5159
Mailing Address 1201 CLOPPER ROAD GAITHERSBURG MD 20878
Business Address 1201 CLOPPER ROAD GAITHERSBURG MD 20878 3019447000
DIGENE CORP (Issuer) CIK: 0001011582 (see all company filings)

EIN.: 521536128 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address SPOORSTRAAT 50 KJ VENLO P7 5911
Business Address SPOORSTRAAT 50 KJ VENLO P7 5911 31-77-320-8400
QIAGEN NV (Reporting) CIK: 0001015820 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-28194 | Film No.: 071010580
SIC: 2836 Biological Products, (No Diagnostic Substances)